Investigational Multi-purpose Contact Lens Care Solution.
Public ClinicalTrials.gov record NCT01055613. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study compares an investigational contact lens care multi-purpose solution to a currently marketed multi-purpose solution.
Study identification
- NCT ID
- NCT01055613
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 312 participants
Conditions and interventions
Conditions
Interventions
- Vistakon Investigational Multi-Purpose Solution I Device
- ReNu MultiPlus Multi-Purpose Solution Device
Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2009 (Type not available)
- Primary completion
- May 2010 (Actual)
- Completion
- Not listed
- Last update posted
- Jun 19, 2018
Started 2009
United States locations
- U.S. sites
- 15
- U.S. states
- 14
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Fresno | California | — | — |
| Not listed | Pismo Beach | California | — | — |
| Not listed | Louisville | Colorado | — | — |
| Not listed | Bloomfield | Connecticut | — | — |
| Not listed | Jacksonville | Florida | — | — |
| Not listed | Overland Park | Kansas | — | — |
| Not listed | East Lansing | Michigan | — | — |
| Not listed | Warrensburg | Missouri | — | — |
| Not listed | Grove City | Ohio | — | — |
| Not listed | Grants Pass | Oregon | — | — |
| Not listed | Kingston | Pennsylvania | — | — |
| Not listed | Sioux Falls | South Dakota | — | — |
| Not listed | Memphis | Tennessee | — | — |
| Not listed | Salt Lake City | Utah | — | — |
| Not listed | Laramie | Wyoming | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01055613, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 19, 2018 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01055613 live on ClinicalTrials.gov.